Tilray, Inc. (NASDAQ: TLRY) shares are trading lower after the company reported worse-than-expected first quarter sales results. The company reported quarterly loss per share of $0.08, which came inline with analyst estimates and sales of $168 million which missed the analyst consensus estimate of $172.61 million.
Why is Tilray stock down today?
Nov 18, 2021 · Tilray, Inc. TLRY shares are trading lower after Barclays initiated coverage on the stock with an Underweight rating and a $10 price target. Barclays analyst Gaurav Jain notes 'the US leaf touching...
Is Tilray’s Bottom Line strong enough to beat the mean?
The decline is steady despite short float at just 7%. The small bear position in Tilray stock is due to the high cost of borrowing shares to short it. By comparison, the short-flat in Canopy Growth...
How good are Tilray's Q2 results?
May 07, 2021 · Now what. With a large global geographic footprint, industry-leading operational scale, and low-cost production facilities, Tilray is poised to compete and win in the rapidly expanding cannabis ...
Is TLRY stock a buy at $300?
Shares of Tilray ( TLRY) had fallen 11.5% as of 11:03 a.m. EST on Tuesday. The drop resulted from the Canadian cannabis producer's disappointing fourth-quarter update after the …
See more
Feb 17, 2021 · Tilray (NASDAQ: TLRY) stock was down 9.6% after tumbling 11.5% earlier. ... So what. There's a good reason why investors might be jittery about Tilray's Q4 update. The company has delivered anemic ...
Is Tilray a good buy now?
What is the future of Tilray stock?
The 15 analysts offering 12-month price forecasts for Tilray Brands Inc have a median target of 7.25, with a high estimate of 23.00 and a low estimate of 4.50. The median estimate represents a +65.15% increase from the last price of 4.39.
Will Tilray stock go back up?
...
Tilray's fiscal Q1 2022 results.
| Long position overnight fee | -0.0225% |
|---|---|
| Overnight fee time | 21:00 (UTC) |
| Spread | 1.46 |
Is Tilray a good stock to hold?
Should I sell my Tilray stock?
Is Tilray a buy Zacks?
...
(Real Time Quote from BATS)
| Zacks Rank | Definition | Annualized Return |
|---|---|---|
| 1 | Strong Buy | 24.97% |
| 2 | Buy | 18.45% |
| 3 | Hold | 10.03% |
| 4 | Sell | 5.70% |
Is Tilray a good stock to buy 2021?
Who invested in Tilray?
| Stockholder | Stake | Shares owned |
|---|---|---|
| ETF Managers Group LLC | 1.56% | 7,489,407 |
| Susquehanna Financial Group LLLP | 1.54% | 7,390,234 |
| Renaissance Technologies LLC | 1.08% | 5,211,591 |
| Dimensional Fund Advisors LP | 0.64% | 3,056,889 |
What is the main problem with Tilray?
So what. The main problem for Tilray is that the trends aren't its friends. Both the top and bottom lines for the company are heading in the wrong direction. Tilray's primary issue on the top line is that its bulk cannabis revenue plunged nearly 61% from Q3.
How much did Tilray lose in Q4?
Tilray announced Q4 revenue of $23 million, down 8% from the previous quarter. It also reported a big net loss in Q4 of $219.1 million, or $2.14 per share. This loss was significantly worse than the company's net loss in the third quarter of 2019.
Does Tilray lose money?
But the biggest challenge for Tilray overall is that it continues to lose a boatload of money. The company's deteriorating bottom line is concerning. Granted, there were some one-time items that caused the net loss in Q4 to be worse than it would otherwise have been. Tilray recorded over $68 million in inventory adjustments and wrote down over $112 million related to its collaboration with Authentic Brands Group. But the net loss would have been substantial even without these items.
Is Tilray stock volatile?
In addition, the company has cut costs significantly as part of a restructuring announced last month. Still, expect Tilray stock to remain highly volatile this year.
How much money will Tilray make in 2024?
In his interview with New Cannabis Ventures, CEO Simon Irwin said that Tilray could generate $4bn of sales in Europe by the end of 2024. However, it’s important to note that these markets are only just starting to open up to cannabis, making them both small and uncertain.
How much will Tilray stock fall in 2021?
The service’s Tilray stock prediction is $11.75 for the end of 2021, $12.84 for the end of 2022, $14.67 for the end of 2023, $15.79 for the end of 2024 and $18.19 by the end of 2025.
What is the difference between CFD and stock?
The main difference between CFD trading and trading assets, such as commodities and stocks, is that you don’t own the underlying asset when you trade on a CFD.
How many states have legalized marijuana?
Currently, 36 states and the District of Columbia have legalised the medical use of marijuana. Meanwhile, 18 states along with DC have legalised the recreational use of cannabis. Marijuana remains illegal under Federal Law.
Is tilray trending lower?
Tilray has been trending lower after reaching its all-time high of $67 in February. The price recently faced rejection at the descending trendline resistance and is now extending its decline below the 50-day simple moving average (SMA). A move below the 50-day SMA combined with the RSI falling below 50 into bearish territory suggests that there could be more downside to come.
Does Tilray own Medmen?
However, this would only happen in the case that cannabis is legalised at federal level in the US and even then, Tilray would only own a 21% stake of the company, a small percentage of what is expected to be a huge growth industry .
Does Tilray sell cannabis?
Along with being the largest share of the recreational and medical cannabis markets in Canada, the firm is also the market leader for medical cannabis in Germany. While it doesn’t sell cannabis in the US yet, it is raking in some revenue from beer sales through its SweetWater Brewing Company subsidiary there.
